Ventas, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 14, 2024 at 04:15 pm EST
Share
Ventas, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 377.36 million compared to USD 347.59 million a year ago. Revenue was USD 1,164.39 million compared to USD 1,051.43 million a year ago. Net loss was USD 90.82 million compared to USD 45.02 million a year ago. Basic loss per share from continuing operations was USD 0.23 compared to USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 0.23 compared to USD 0.11 a year ago.
For the full year, sales was USD 1,486.4 million compared to USD 1,399.31 million a year ago. Revenue was USD 4,497.83 million compared to USD 4,129.19 million a year ago. Net loss was USD 40.97 million compared to USD 47.45 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.1 compared to USD 0.12 a year ago.
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).